These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1027 related articles for article (PubMed ID: 12150915)
1. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Manning BD; Tee AR; Logsdon MN; Blenis J; Cantley LC Mol Cell; 2002 Jul; 10(1):151-62. PubMed ID: 12150915 [TBL] [Abstract][Full Text] [Related]
2. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. Tee AR; Anjum R; Blenis J J Biol Chem; 2003 Sep; 278(39):37288-96. PubMed ID: 12867426 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. Dan HC; Sun M; Yang L; Feldman RI; Sui XM; Ou CC; Nellist M; Yeung RS; Halley DJ; Nicosia SV; Pledger WJ; Cheng JQ J Biol Chem; 2002 Sep; 277(38):35364-70. PubMed ID: 12167664 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions. Han S; Santos TM; Puga A; Roy J; Thiele EA; McCollin M; Stemmer-Rachamimov A; Ramesh V Cancer Res; 2004 Feb; 64(3):812-6. PubMed ID: 14871804 [TBL] [Abstract][Full Text] [Related]
6. 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). Liu MY; Cai S; Espejo A; Bedford MT; Walker CL Cancer Res; 2002 Nov; 62(22):6475-80. PubMed ID: 12438239 [TBL] [Abstract][Full Text] [Related]
7. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Tee AR; Fingar DC; Manning BD; Kwiatkowski DJ; Cantley LC; Blenis J Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13571-6. PubMed ID: 12271141 [TBL] [Abstract][Full Text] [Related]
8. United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Manning BD; Cantley LC Biochem Soc Trans; 2003 Jun; 31(Pt 3):573-8. PubMed ID: 12773158 [TBL] [Abstract][Full Text] [Related]
9. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565 [TBL] [Abstract][Full Text] [Related]
11. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). Goncharova EA; Goncharov DA; Eszterhas A; Hunter DS; Glassberg MK; Yeung RS; Walker CL; Noonan D; Kwiatkowski DJ; Chou MM; Panettieri RA; Krymskaya VP J Biol Chem; 2002 Aug; 277(34):30958-67. PubMed ID: 12045200 [TBL] [Abstract][Full Text] [Related]
12. Signaling from Akt to FRAP/TOR targets both 4E-BP and S6K in Drosophila melanogaster. Miron M; Lasko P; Sonenberg N Mol Cell Biol; 2003 Dec; 23(24):9117-26. PubMed ID: 14645523 [TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809 [TBL] [Abstract][Full Text] [Related]
14. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway. Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867 [TBL] [Abstract][Full Text] [Related]
15. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Lu KH; Wu W; Dave B; Slomovitz BM; Burke TW; Munsell MF; Broaddus RR; Walker CL Clin Cancer Res; 2008 May; 14(9):2543-50. PubMed ID: 18451215 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739 [TBL] [Abstract][Full Text] [Related]
17. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Liang J; Slingerland JM Cell Cycle; 2003; 2(4):339-45. PubMed ID: 12851486 [TBL] [Abstract][Full Text] [Related]
18. Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. Radimerski T; Montagne J; Hemmings-Mieszczak M; Thomas G Genes Dev; 2002 Oct; 16(20):2627-32. PubMed ID: 12381661 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140 [TBL] [Abstract][Full Text] [Related]
20. Loss of PTEN expression leading to high Akt activation in human multiple myelomas. Hyun T; Yam A; Pece S; Xie X; Zhang J; Miki T; Gutkind JS; Li W Blood; 2000 Nov; 96(10):3560-8. PubMed ID: 11071655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]